腹膜透析液、腹膜透析液セット、腹膜透析に使用される組成物および腹膜透析を行う方法

• Format: Patent
• Language: Japanese
• Published: 25.02.2021
• Subjects: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

本発明は、腹膜透析治療において、低ナトリウム血症を起こすことなく、残腎機能への悪影響を回避しながら、水とナトリウムとのバランスを適切に管理することのできる手段を提供する。１．５〜１．８ｗ／ｖ％のグルコースおよび１２０〜１３０ｍＥｑ／Ｌのナトリウムを含み、１日当たり１〜２回単独で使用される、腹膜透析液であって、１日当たり３〜５回、１回１．５〜２．０Ｌの量を対象の腹腔内に注入、貯留および排液する腹膜透析に、１．３５〜２．５ｗ／ｖ％のグルコースおよび１３２〜１３５ｍＥｑ／Ｌのナトリウムを含む他の腹膜透析液と組み合わせて使用される、腹膜透析液。 The present invention is to provide a means capable of properly balancing water and sodium in peritoneal dialysis treatment, without causing hyponatremia, while avoiding adversely affecting residual renal function. A peritoneal dialysate containing 1.5 to 1.8 w/v% of glucose and 120 to 130 mEq/L of sodium, and being for independent use once or twice a day, wherein the peritoneal dialysate is used in combination with another peritoneal dialysate that contains 1.35 to 2.5 w/v% of glucose and 132 to 135 mEq/L of sodium, in peritoneal dialysis that involves injection of an amount of 1.5 to 2.0 L per one time in an abdominal cavity of a subject, storage and drainage three to five times a day.